Revalidation of the RACE scale in Catalonia

Published in J Neurointerv Surg 2018 (Carrera et al)

In a sample of 1822 patients with stroke code activation, it is confirmed that the RACE scale is an effective tool to identigy patients with large vessel occlusion who are candidates for endovascular treatment (AUC 0.76).

In addition, the study shows that, in patients with RACE>4 (suspicion of large vessel occlusion), direct access to an endovascular center multiplies by 2.4 the probability of receiving the treatment compared to its transfer to a closer center, requiring in these cases a transfer between hospitals.

 

External validation and implementation in other areas:

Toledo, Ohio – Zaidi, JINS 2016; Jumaa, JINS 2020; Krebs, Air Medical Journal 2024

Berlin, Germany (model-based approaches) – Schlemm et al – Stroke 2017; Schlemm et al – BMC Neurol 2018

Hollywood, FL – Metha, Stroke 2018

Pittsburgh, PA – Rahangdale, Neurology 2018

Houston, Texas – Dickson, Prehosp Emergency Care 2019

Serbia – Prokin, ABC časopis urgentne medicine 2019

Louisville, KY – Cruz, J Neurointerv Surg 2020; James, JINS 2020

Netherlands – Nguyen, JAMA Neurology 2020; Dekker – SVIN, 2023

PRESTO trial, Netherlands – Duvekot, Lancet Neurology 2021

Greenville, South Carolina – Thavarajah, J Stroke and Cerebrovasc Dis 2022

Teheran, Iran – Rafiemanesh, BMC Emergency Medicine 2023

Basel, Switzerland Front Neurol 2023

Vietnam – Truong, Cerebrovasc Dis Extra 2025

Netherlands – Dekker, Neurology 2025

 

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *